Cargando…
Engineering NK-CAR.19 cells with the IL-15/IL-15Rα complex improved proliferation and anti-tumor effect in vivo
INTRODUCTION: Natural killer 92 (NK-92) cells are an attractive therapeutic approach as alternative chimeric antigen receptor (CAR) carriers, different from T cells, once they can be used in the allogeneic setting. The modest in vivo outcomes observed with NK-92 cells continue to present hurdles in...
Autores principales: | Silvestre, Renata Nacasaki, Eitler, Jiri, de Azevedo, Julia Teixeira Cottas, Tirapelle, Mariane Cariati, Fantacini, Daianne Maciely Carvalho, de Souza, Lucas Eduardo Botelho, Swiech, Kamilla, Covas, Dimas Tadeu, Calado, Rodrigo T., Montero, Paola Ortiz, Malmegrim, Kelen Cristina Ribeiro, Figueiredo, Marxa L., Tonn, Torsten, Picanço-Castro, Virginia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561086/ https://www.ncbi.nlm.nih.gov/pubmed/37818365 http://dx.doi.org/10.3389/fimmu.2023.1226518 |
Ejemplares similares
-
The F309S mutation increases factor VIII secretion in human cell line
por: Fantacini, Daianne Maciely Carvalho, et al.
Publicado: (2016) -
Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy
por: Schmidt, Dayane, et al.
Publicado: (2022) -
Establishment of a simple and efficient platform for car-t cell generation and expansion: from lentiviral production to in vivo studies
por: Picanço-Castro, Virgínia, et al.
Publicado: (2020) -
Combination of genetically engineered T cells and immune checkpoint blockade for the treatment of cancer
por: Rossetti, Rafaela, et al.
Publicado: (2022) -
Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19
por: Rocha, José Lucas Martins, et al.
Publicado: (2020)